Latest news and stories about obesity treatment in Portugal for expats and residents.
Experts and patients denounced, this Wednesday, a discriminatory treatment of obesity compared to other chronic diseases.
“That well-known slogan about the patient being at the centre of the care pathway and care delivery is not happening,” says Nuno Jacinto, president of the Portuguese Association of General and Family Medicine.
The US drug regulator on Monday approved the first tablet version of the anti‑obesity treatment Wegovy, offering an alternative to injections for weight loss, the Danish pharmaceutical company Novo Nordisk announced.
New drugs are being developed, but it is uncertain whether they will be available in the Portuguese market by 2026. An expert indicates that, in addition to weight loss, they will be important for reducing diseases associated with the condition.
For the first time, the World Health Organization suggests the use of a medication for the treatment of obesity. The WHO states that diabetes medications, which have been widely used for weight loss, should be increasingly accessible to the general population and urges different countries to adopt public policies that allow for the widespread use of these medications. In this morning's Expresso, Paulo Baldaia talks with João Jácome de Castro, outgoing president of the Portuguese Society of Endocrinology, Diabetes and Metabolism, and an endocrinologist at the Armed Forces Hospital.
